Suppr超能文献

经玻璃体内注射治疗的患者的眼内液细胞因子水平降低。

Tear cytokine levels are reduced in patients treated with intravitreal injections.

机构信息

Department of Ophthalmology, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Department of Ophthalmology, Stavanger University Hospital, Stavanger, Norway; Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway.

出版信息

Ocul Surf. 2024 Apr;32:222-226. doi: 10.1016/j.jtos.2024.03.004. Epub 2024 Mar 13.

Abstract

PURPOSE

To investigate cytokine levels in the tear fluid of patients receiving serial intravitreal injections (IVI) with anti-vascular endothelial growth factor (anti-VEGF) for neovascular age-related macular degeneration (nAMD).

METHODS

Concentrations of six cytokines (IFN-γ, IL-1β, IL-6, IL-8, TNF and VEGF) in tears of patients receiving anti-VEGF in one eye were assayed using multiplex cytometric bead array. The fellow untreated eye served as control. Tear sampling was performed on a single occasion at a minimum of four weeks after IVI. Patients underwent a pre-IVI antisepsis protocol with povidone-iodine.

RESULTS

Tear fluid from thirty patients with a mean age of 78.8 years (range 58-90) was assayed. Subjects received a median of 43.5 (range 22-106) IVI in one eye. The median level of IFN-γ was 0.33 (interquartile range (IQR) 0.22-0.52) pg/mg of total protein in injected eyes versus 0.41 (IQR 0.21-1.05) pg/mg in fellow eyes (p = 0.017). For TNF, a median level of 0.12 (IQR 0.08-0.18) pg/mg of total protein was found in injected eyes versus 0.14 (IQR 0.07-0.33) pg/mg of total protein in fellow eyes (p = 0.019). There were no differences between injected and fellow eyes regarding the levels of IL-1β, IL-6, IL-8 and VEGF.

CONCLUSION

Tear fluid in eyes receiving serial IVI with anti-VEGF and preoperative povidone-iodine antisepsis constitutes lower levels of the pro-inflammatory cytokines IFN-γ and TNF compared to fellow eyes. This provides biochemical support of previous findings of reduced signs of inflammation and healthier tear film parameters in patients treated with serial IVI.

摘要

目的

研究接受抗血管内皮生长因子(anti-VEGF)连续玻璃体内注射(IVI)治疗新生血管性年龄相关性黄斑变性(nAMD)的患者的泪液细胞因子水平。

方法

使用多重细胞因子微珠阵列分析接受抗 VEGF 治疗的一只眼中的 6 种细胞因子(IFN-γ、IL-1β、IL-6、IL-8、TNF 和 VEGF)在泪液中的浓度。未治疗的对侧眼作为对照。在 IVI 后至少 4 周的单个时间点进行泪液取样。患者在接受 IVI 前接受聚维酮碘的消毒方案。

结果

对 30 名平均年龄为 78.8 岁(58-90 岁)的患者的泪液进行了检测。每位患者接受了一只眼中位数为 43.5(22-106)次 IVI。注射眼中 IFN-γ 的中位数水平为 0.33(四分位距(IQR)0.22-0.52)pg/mg 总蛋白,对侧眼为 0.41(IQR 0.21-1.05)pg/mg(p=0.017)。对于 TNF,注射眼中总蛋白的中位数水平为 0.12(IQR 0.08-0.18)pg/mg,对侧眼为 0.14(IQR 0.07-0.33)pg/mg(p=0.019)。注射眼和对侧眼的 IL-1β、IL-6、IL-8 和 VEGF 水平没有差异。

结论

接受抗 VEGF 连续 IVI 和术前聚维酮碘消毒的眼睛的泪液中,促炎细胞因子 IFN-γ 和 TNF 的水平低于对侧眼。这为先前发现的接受连续 IVI 治疗的患者炎症迹象减少和泪膜参数更健康提供了生化支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验